The FDA has approved a generic version of liraglutide (Victoza) for managing blood sugar in type 2 diabetes patients aged…
Browsing: Clinical Updates
The FDA has granted accelerated approval to a combination therapy led by encorafenib (Braftovi) for patients with BRAF V600E-mutant metastatic…
The field of gastroenterology witnessed transformative advancements in 2024, driven by groundbreaking clinical trials, updated practice guidelines, and innovative therapeutic…
Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. Originally released as a bonus episode…
International researchers have identified distinctive bacterial signatures in the gut microbiome that may lead to new, noninvasive diagnostics for inflammatory…
A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has led to the FDA granting a Breakthrough Therapy Designation…
A groundbreaking consensus document, spearheaded by international experts and published in Lancet Gastroenterology & Hepatology, outlines standardized guidelines for microbiota…
OpenBiome, a prominent nonprofit stool bank, has voluntarily suspended the distribution of investigational fecal microbiota transplantation (FMT) preparations for treating…
Individuals with fecal hemoglobin concentrations of 5 µg/g to 40 µg/g face a 5- to 13-fold increased risk for colorectal…
In a groundbreaking head-to-head trial funded by Eli Lilly, Zepbound outperformed Wegovy in weight loss efficacy. Participants on Zepbound shed…